![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Zhao W.-Q. Feng C. Alkon D.L.
Publisher: Elsevier
ISSN: 0969-9961
Source: Neurobiology of Disease, Vol.14, Iss.3, 2003-12, pp. : 458-469
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Yoshimura Y. Ichinose T. Yamauchi T.
Neuroscience Letters, Vol. 353, Iss. 3, 2003-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
P38 MAP kinase is activated at early stages in Alzheimer's disease brain
By Sun A. Liu M. Nguyen X.V. Bing G.
Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The p38 MAP kinase signaling pathway in Alzheimer's disease
By Johnson G.V.W. Bailey C.D.C.
Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. :